Levin Capital Strategies’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Levin Capital Strategies’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,484	Closed	-$16K	–	269
2018 Q4	$16K	Sell	18,484 -32,211	-64%	-$36.4K	﹤0.01%	251
2018 Q3	$150K	Hold	50,695	–	–	﹤0.01%	251
2018 Q2	$187K	Hold	50,695	–	–	﹤0.01%	260
2018 Q1	$177K	Hold	50,695	–	–	﹤0.01%	279
2017 Q4	$158K	Sell	50,695 -107,181	-68%	-$515K	﹤0.01%	286
2017 Q3	$1.11M	Sell	157,876 -2,966	-2%	-$23.8K	0.02%	138
2017 Q2	$1.49M	Sell	160,842 -22,953	-12%	-$221K	0.03%	128
2017 Q1	$1.97M	Sell	183,795 -86,758	-32%	-$887K	0.04%	112
2016 Q4	$2.28M	Buy	+270,553	New	+$2.4M	0.04%	118

Other funds holding NVLN

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

David M. Knott $264M AUM 59.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return